Roche has received conditional marketing approval in Europe for Lunsumio, a new subcutaneous form of its bispecific antibody that can be administered in a quick, one?minute injection. This approval marks one of the significant changes in the...
Tesaro, Inc., a GSK subsidiary, announces that it has filed a lawsuit against AnaptysBio, Inc. in the Delaware Chancery Court. This action asserts that recent behavior of AnaptysBio significantly violates the current licensing agreement with Tesaro
Ramaiah Memorial Hospital and Ramaiah Medical College became the center of global medical innovation with the inauguration of the Worldwide Network for Blood and Marrow Transplantation (WBMT) Symposium on Cell Therapy
Actimed Therapeutics today announced a licensing agreement with Mankind Pharma, giving the company exclusive rights to develop and commercialise Actimed’s products for the treatment and prevention of cachexia across India and several South Asian...
GSK and the Fleming Initiative have declared six new antimicrobial resistance (AMR) research programmes to help in reducing the increase of drug-resistant infections. The announcement follows the WHO GLASS report of October 2025 which estimates that
In a remarkable humanitarian initiative, the 14th edition of the free Plastic Surgery Camp, organized by Akums, in collaboration with Rotary International Club and Interplast Germany, has once again ignited hope among hundreds of underserved patients
Eli Lilly and Company (India) Pvt. Ltd. has obtained CDSCO marketing approval for donanemab. The medication provides an alternative therapy to adults experiencing early symptomatic Alzheimer disease...
OMRON Healthcare Co., Ltd. has revealed further investment in the India-focused AI medtech startup TRICOG HEALTH INDIA PRIVATE LIMITED
Sanofi’s type?1 diabetes therapy Teizeild (teplizumab) has been recommended for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use. This makes Teizeild the first disease-modifying therapy to type 1 diabetes...
Danish pharmaceutical company Novo Nordisk (NOVOb.CO), opens new tab announced on Tuesday that it has reduced the price of its weight-loss medication, Wegovy, by as much as 37% from its initial launch price in India, as it aims to strengthen